Page 1 of Clinical Trials for Drug vorinostat, 205 Total Matches
- 1RecruitingLast Updated: February 13, 2012Condition(s): Hematologic Malignancies; Graft vs Host Disease
- 2WithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaLast Updated: May 9, 2012Condition(s): Multiple Myeloma
- 3RecruitingLast Updated: February 24, 2012Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
- 4RecruitingLast Updated: February 13, 2012Condition(s): Hodgkin's Disease; Non-Hodgkin's Lymphoma
- 5RecruitingLast Updated: July 19, 2011Condition(s): Non-small Cell Lung Cancer
- 6Active, not recruitingLast Updated: October 11, 2011Condition(s): Multiple Myeloma
- 7CompletedLast Updated: July 6, 2011Condition(s): Non-Small Cell Lung Cancer
- 8RecruitingLast Updated: February 16, 2012Condition(s): Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
- 9RecruitingLast Updated: June 9, 2011Condition(s): Lymphoma
- 10Active, not recruitingLast Updated: October 13, 2009Condition(s): Breast Cancer
- 11Active, not recruitingLast Updated: April 25, 2012Condition(s): Pancreatic Cancer; Adenocarcinoma of the Pancreas
- 12RecruitingLast Updated: February 7, 2012Condition(s): Solid Tumors; Relapsed/Refractory Sarcomas
- 13CompletedLast Updated: January 21, 2010Condition(s): B-Cell Lymphoma
- 14CompletedLast Updated: June 14, 2011Condition(s): Advanced Cancer
- 15Not yet recruitingLast Updated: December 28, 2011Condition(s): Multiple Myeloma
- 16RecruitingLast Updated: March 2, 2012Condition(s): Brain and Central Nervous System Tumors
- 17RecruitingLast Updated: April 12, 2012Condition(s): Lymphoma
- 18RecruitingLast Updated: May 24, 2012Condition(s): Leukemia; Myelodysplastic Syndromes
- 19RecruitingLast Updated: December 14, 2007Condition(s): Breast Cancer
- 20Active, not recruitingLast Updated: February 29, 2012Condition(s): Hodgkin's Disease; Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+vorinostat
